GlaxoSmithKline plc
GSK.SWFinancial Statements
Income Statement (Annual)
Amounts in millions
2022
12/31/2022
Revenue
33,136
Cost of Revenue
10,796
Gross Profit
22,340
Gross Margin
67.4%
Operating Income
18,692
Operating Margin
56.4%
Net Income
5,561
Net Margin
16.8%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
9,950
EBITDA Margin
30.0%
2021
12/31/2021
Revenue
38,549
Cost of Revenue
13,111
Gross Profit
25,437
Gross Margin
66.0%
Operating Income
6,232
Operating Margin
16.2%
Net Income
5,758
Net Margin
14.9%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
9,888
EBITDA Margin
25.6%
2020
12/31/2020
Revenue
38,532
Cost of Revenue
13,226
Gross Profit
25,306
Gross Margin
65.7%
Operating Income
8,119
Operating Margin
21.1%
Net Income
7,218
Net Margin
18.7%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
11,498
EBITDA Margin
29.8%
2019
12/31/2019
Revenue
38,142
Cost of Revenue
13,405
Gross Profit
24,737
Gross Margin
64.9%
Operating Income
7,326
Operating Margin
19.2%
Net Income
5,953
Net Margin
15.6%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
10,667
EBITDA Margin
28.0%
2018
12/31/2018
Revenue
34,828
Cost of Revenue
11,572
Gross Profit
23,255
Gross Margin
66.8%
Operating Income
5,817
Operating Margin
16.7%
Net Income
4,572
Net Margin
13.1%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
7,915
EBITDA Margin
22.7%